ENTRA
  • 17th Meet The Professor Advanced International Breast Cancer Course (AIBCC), IN-CLASS COURSE

    Mortality from breast cancer is declining in most countries thanks to effective screening programs, early diagnosis, molecular characterization of the different subtypes and biology-driven treatments. A multidisciplinary management of breast cancer patients is therefore the key to success and a breast multidisciplinary team should include - besides the “classic” clinical specialties - pathologists, molecular biologists and geneticists. Furthermore, the availability of multiple diagnostic and therapeutic choices, the increasing costs of new technologies and drugs and the issue of sustainability represent a new challenge for socially-responsible clinicians.  With this goal in mind, the Programme includes lectures on molecular characterization, updated treatments of early and advanced disease, management of difficult cases and hereditary syndromes and issues of sustainability and drug access across countries.

    The in-class course will take place at the venue specified underneath. Please note that due to COVID mitigation measures, the availability of places for the in-presence course is limited.

    The in-class course, with the participation of speakers connected from various countries and local speakers present at the meeting venue, is addressed primarily to Italian participants. The official language of the course is English. No simultaneous translation will be provided.

  • Programma dell'attività formativa

    THURSDAY, SEPTEMBER 30TH

    14.30 - Registration of participants

    14.45 - Introduction to the Conference (Pier Franco Conte, Gabriel N. Hortobagyi, Valentina Guarneri, Philip Poortmans)

    SESSION I
    Chairpersons: Hesham Ahmed Gaballah Elghazaly, Pierfranco Conte

    15.00 - Obesity and Cancer (Roberto Vettor)

    15.20 - Management of women BRCA1/2 and other predisposition gene mutations (Shani Paluch-Shimon)

    15.40 - Axillary dissection: still an option? (Elefterios Mamounas)

    16.00 - Hot topics in breast cancer RT (Philip Poortmans)

    16.20 - Clinical impact of genomics in BC (Aleix Prat)

    16.40 - PIK3CA testing: from technical aspects to clinical application (Sybille Loibl)

    17.00 - Prognostic signatures to guide treatment decision (Gabriel N. Hortobagyi)

    17.20 - Q&A

    17.30 - Adjourn

    FRIDAY, OCTOBER 1ST


    SESSION II –MULTIDISCIPLINARY TUMOR BOARD   

    Chairperson: Pier Franco Conte, Valentina Guarneri

    10.00 - Clinical case 1: omission of RT in elderly patients with low-risk tumor (Franco Berti)

    10.20 - Clinical case 2: cT1c, cN0 HER2+tumor: neo vs adjuvant (option to escalate or de-escalate therapy) (Cristina Falci)

    10.40 - Clinical case  3: post-neoadjuvant therapy in patients with RD (stressing the concept of RCB and characterization of RD) (Federica Miglietta)

    11.00 - Clinical case 4: oligometastatic disease (Grazia Vernaci)

    11.20 - Clinical case

    12.00 - Lunch

    SESSION III
    Chairpersons: Jacek Jassem, Valentina Guarneri

    14.30 - Adjuvant CDK4/6i for HR+ disease: reconciling data from randomized trials (Valentina Guarneri)

    14.50 - Early BRCAm tumors: PARPi are coming! (Pier Franco Conte)

    15.10 - Neoadjuvant therapy for early breast cancer: beyond the pCR dogma (Pier Franco Conte)

    15.30 - Immunotherapy for early TNBC: hopes and hypes (Hope Rugo)

    15.50 - Q&A

    16.10 - Antibody Drug Conjugates for BC (Frederik Marmè)

    16.30 - Targeting unconventional pathways in Luminal BC (Maria Vittoria Dieci)

    16.50 - Treatment algorithm for HR+/HER2- ABC (Stephen Johnston)

    17.10 - Treatment algorithm for HER2+ ABC (Sandra Swain)

    17.30 - Treatment algorithm and new options for TN ABC (Miguel Martin)

    17.50 - Q&A

    18.10 - Adjourn

  • Obiettivo formativo nazionale

    Contenuti tecnico-professionali (conoscenze e competenze) specifici di ciascuna professione, di ciascuna specializzazione e di ciascuna attività ultraspecialistica, ivi incluse le malattie rare e la medicina di genere

  • Istruzioni ECM

    Per completare il percorso formativo e ottenere i crediti ECM previsti, l’utente deve soddisfare tutte le seguenti condizioni:

    1. Appartenere a una professione/disciplina corrispondente a quelle previste dall'accreditamento ECM;
    2. Partecipare ad almeno il 90% della durata dell’evento;
    3. Compilare la scheda di valutazione dell’evento - resa disponibile ESCLUSIVAMENTE ONLINE al termine dell’evento stesso - entro e non oltre la mezzanotte del 3° giorno successivo a quello in cui si è terminata l'attività formativa;
    4. Superare con successo il test di verifica dell’apprendimento - reso disponibile ESCLUSIVAMENTE ONLINE al termine dell’evento stesso - entro e non oltre la mezzanotte del 3° giorno successivo a quello in cui si è terminata l'attività formativa. Il test consiste in un questionario a risposta multipla con una sola risposta corretta per ciascuna domanda. E' consentito un solo tentativo ed è considerato superato con successo quando si risponde correttamente ad almeno il 75% delle domande.